These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28027796)

  • 1. Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation.
    Hu X; Ma X; Luo Y; Xu Y; Xiong Q; Pan X; Xiao Y; Bao Y; Jia W
    Clin Nutr; 2018 Feb; 37(1):223-228. PubMed ID: 28027796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women.
    Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y
    Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status.
    Hu X; Xiong Q; Xu Y; Zhang X; Pan X; Ma X; Bao Y; Jia W
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):119-125. PubMed ID: 29174027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of serum adipocyte fatty acid binding protein with body composition and fat distribution in nondiabetic Chinese women.
    Hao Y; Ma X; Luo Y; Hu X; Pan X; Xiao Y; Bao Y; Jia W
    J Clin Endocrinol Metab; 2015 May; 100(5):2055-62. PubMed ID: 25719934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
    Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function.
    Natsuki Y; Morioka T; Fukumoto S; Kakutani Y; Yamazaki Y; Ochi A; Kurajoh M; Mori K; Shoji T; Imanishi Y; Inaba M; Emoto M
    Endocr J; 2022 Feb; 69(2):121-129. PubMed ID: 34497173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of a first-degree family history of diabetes to increased serum adipocyte fatty acid binding protein levels independent of body fat content and distribution.
    Hu X; Pan X; Ma X; Luo Y; Xu Y; Xiong Q; Xiao Y; Bao Y; Jia W
    Int J Obes (Lond); 2016 Nov; 40(11):1649-1654. PubMed ID: 27534843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial fat, body mass index, and triglyceride are independent contributors of serum fibroblast growth factor 21 level in obese premenopausal women.
    Akyildiz ZI; Polat S; Yurekli BS; Kocabas GU; Tuluce K; Tuluce SY; Kocabas U; Bozkaya G; Yuksel A; Nazli C
    J Endocrinol Invest; 2015 Mar; 38(3):361-6. PubMed ID: 25312836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive relationship between serum low-density lipoprotein cholesterol levels and visceral fat in a Chinese nondiabetic population.
    Luo Y; Ma X; Shen Y; Hao Y; Hu Y; Xiao Y; Bao Y; Jia W
    PLoS One; 2014; 9(11):e112715. PubMed ID: 25398089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.
    Lee J; Lee JY; Lee JH; Jung SM; Suh YS; Koh JH; Kwok SK; Ju JH; Park KS; Park SH
    Arthritis Res Ther; 2015 Mar; 17(1):79. PubMed ID: 25889813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 levels decline following sleeve gastrectomy.
    Billington EO; Murphy R; Gamble GD; Callon K; Davies N; Plank LD; Booth M; Reid IR
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):87-93. PubMed ID: 30943313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear relationships between visceral fat area and percent regional fat mass in the trunk and the lower limbs in Japanese adults.
    Demura S; Sato S
    Eur J Clin Nutr; 2008 Dec; 62(12):1395-404. PubMed ID: 17805228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
    He X; Hu X; Ma X; Su H; Ying L; Peng J; Pan X; Bao Y; Zhou J; Jia W
    Cardiovasc Diabetol; 2017 Jun; 16(1):77. PubMed ID: 28619026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
    de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
    Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat mass, abdominal fat distribution, and C-reactive protein concentrations in overweight and obese men and women.
    Maki KC; Rains TM; Bell M; Reeves MS; Farmer MV; Yasunaga K
    Metab Syndr Relat Disord; 2011 Aug; 9(4):291-6. PubMed ID: 21466377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes.
    Hu X; Ma X; Luo Y; Xu Y; Xiong Q; Pan X; Bao Y; Jia W
    Sci Rep; 2016 Oct; 6():34696. PubMed ID: 27698482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.
    Domingo P; Lamarca MK; Gallego-Escuredo JM; Torres F; Domingo JC; Villarroya J; Gutierrez Mdel M; Mateo MG; Vidal F; Villarroya F; Giralt M
    J Antimicrob Chemother; 2015; 70(6):1825-32. PubMed ID: 25700720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between circulating fibroblast growth factor-23 and age-related cardiovascular-renal parameters in a healthy Chinese population.
    Wang N; Bai X; Jin B; Han W; Sun X; Chen X
    Geriatr Gerontol Int; 2017 Aug; 17(8):1221-1231. PubMed ID: 27427468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.